NFKB1 and neoplasm: Although exact molecular networks causing radioadaptive tumor resistance in HER2-negative tumors are still largely unknown, data in our laboratory indicated that expression of HER2 is controlled by NF-κB, which is associated with FIR-induced radioresistance.